Mr. Kazam is responsible for sourcing, evaluating, and overseeing Breakthrough’s new investment and development activity across all U.S. markets. Prior to joining Breakthrough, Mr. Kazam played a key role in establishing the Breakthrough platform at Tishman Speyer. While at Tishman Speyer, Mr. Kazam also helped lead $3B of acquisitions and financings, and managed pre-development of Tishman Speyer’s Hudson Yards properties, including a 2.8M square foot iconic tower anchored by Pfizer. Mr. Kazam received an MBA from Columbia University and a Bachelor of Architecture from Cornell University.